Analysis	O
of	O
BCL-6	O
mutations	O
in	O
classic	O
Hodgkin	O
disease	O
of	O
the	O
B-	B-cell_type
and	I-cell_type
T-cell	I-cell_type
type	I-cell_type
.	O

BCL-6	B-DNA
is	O
essential	O
for	O
germinal	O
center	O
formation	O
and	O
thus	O
for	O
affinity	O
maturation	O
of	O
immunoglobulin	B-DNA
(	I-DNA
Ig	I-DNA
)	I-DNA
genes	I-DNA
by	O
somatic	O
mutations	O
.	O

The	O
5'-noncoding	B-DNA
region	I-DNA
of	O
the	O
BCL-6	B-DNA
gene	I-DNA
is	O
even	O
a	O
target	O
for	O
the	O
mutation	O
machinery	O
.	O

Translocations	O
of	O
the	O
BCL-6	B-DNA
gene	I-DNA
to	O
heterologous	B-DNA
promoters	I-DNA
and	O
mutations	O
of	O
its	O
5'-noncoding	B-DNA
regulatory	I-DNA
region	I-DNA
were	O
reported	O
to	O
be	O
potential	O
mechanisms	O
for	O
deregulating	O
BCL-6	B-DNA
expression	O
and	O
for	O
playing	O
a	O
role	O
in	O
the	O
genesis	O
of	O
non-Hodgkin	O
lymphoma	O
.	O

In	O
line	O
with	O
this	O
hypothesis	O
is	O
the	O
observation	O
that	O
B-cell	O
lymphoma	O
with	O
somatic	O
mutations	O
,	O
such	O
as	O
diffuse	O
large	O
B-cell	O
lymphoma	O
and	O
follicular	O
lymphoma	O
,	O
also	O
carry	O
BCL-6	O
mutations	O
,	O
some	O
of	O
which	O
are	O
recurrently	O
detectable	O
.	O

Classic	O
Hodgkin	O
disease	O
(	O
cHD	O
)	O
is	O
also	O
derived	O
from	O
B	B-cell_type
cells	I-cell_type
with	O
high	O
loads	O
of	O
somatic	O
mutations	O
and	O
thus	O
a	O
further	O
candidate	O
for	O
BCL-6	O
mutations	O
.	O

To	O
determine	O
the	O
presence	O
and	O
potential	O
role	O
of	O
BCL-6	O
mutations	O
in	O
cHD	O
,	O
the	O
5'-noncoding	B-DNA
BCL-6	I-DNA
proportion	O
of	O
single	B-cell_type
Hodgkin	I-cell_type
and	I-cell_type
Reed-Sternberg	I-cell_type
(	I-cell_type
HRS	I-cell_type
)	I-cell_type
cells	I-cell_type
from	O
6	O
cases	O
of	O
cHD	O
and	O
6	O
cases	O
of	O
HD-derived	B-cell_line
cell	I-cell_line
lines	I-cell_line
was	O
analyzed	O
.	O

All	O
B-cell-derived	O
HD	O
cases	O
and	O
cell	O
lines	O
harbored	O
BCL-6	O
mutations	O
.	O

In	O
contrast	O
,	O
both	O
T-cell-derived	O
HD	O
cases	O
and	O
cell	O
lines	O
were	O
devoid	O
of	O
BCL-6	O
mutations	O
.	O

With	O
only	O
one	O
exception	O
,	O
there	O
were	O
no	O
lymphoma-specific	O
recurrent	O
BCL-6	O
mutations	O
detected	O
,	O
and	O
BCL-6	B-protein
protein	I-protein
was	O
absent	O
from	O
the	O
HRS	B-cell_type
cells	I-cell_type
of	O
most	O
cases	O
.	O

In	O
conclusion	O
,	O
(	O
1	O
)	O
somatic	O
BCL-6	O
mutations	O
are	O
restricted	O
to	O
cHD	O
cases	O
of	O
B-cell	B-cell_type
origin	O
,	O
and	O
(	O
2	O
)	O
the	O
BCL-6	O
mutations	O
represent	O
mostly	O
irrelevant	O
somatic	O
base	O
substitutions	O
without	O
consequences	O
for	O
BCL-6	B-protein
protein	I-protein
expression	O
and	O
the	O
pathogenesis	O
of	O
cHD	O
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NEOPLASIA	NULL
Analysis	NULL
of	NULL
BCL-6	NULL
mutations	NULL
in	NULL
classic	NULL
Hodgkin	NULL
disease	NULL
of	NULL
the	NULL
B-	NULL
and	NULL
T-cell	NULL
type	NULL
Volkhard	NULL
Seitz	NULL
,	NULL
Michael	NULL
Hummel	NULL
,	NULL
loannis	NULL
Anagnostopoulos	NULL
,	NULL
and	NULL
Harald	NULL
Stein	NULL
BCL-6	NULL
is	NULL
essential	NULL
for	NULL
germinal	NULL
center	NULL
formation	NULL
and	NULL
thus	NULL
for	NULL
affinity	NULL
maturation	NULL
of	NULL
immunoglobulin	NULL
(	NULL
ig	NULL
)	NULL
genes	NULL
by	NULL
somatic	NULL
mutations	NULL
.	NULL

The	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
is	NULL
even	NULL
a	NULL
target	NULL
for	NULL
the	NULL
mutation	NULL
machinery	NULL
.	NULL

Translocations	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
to	NULL
heterologous	NULL
promoters	NULL
and	NULL
mutations	NULL
of	NULL
its	NULL
5-noncoding	NULL
regulatory	NULL
region	NULL
were	NULL
reported	NULL
to	NULL
be	NULL
potential	NULL
mechanisms	NULL
for	NULL
deregulating	NULL
BCL-6	NULL
expression	NULL
and	NULL
for	NULL
playing	NULL
a	NULL
role	NULL
in	NULL
the	NULL
genesis	NULL
of	NULL
non-Hodgkin	NULL
lymphoma	NULL
.	NULL

In	NULL
line	NULL
with	NULL
this	NULL
hypothesis	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
B-cell	NULL
Iymphoma	NULL
with	NULL
somatic	NULL
mutations	NULL
,	NULL
such	NULL
as	NULL
diffuse	NULL
large	NULL
B-cell	NULL
lymphoma	NULL
and	NULL
follicular	NULL
Iymphoma	NULL
,	NULL
also	NULL
carry	NULL
BCL-6	NULL
mutations	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
recurrently	NULL
detectable	NULL
.	NULL

Classic	NULL
Hodgkin	NULL
disease	NULL
(	NULL
cHD	NULL
)	NULL
is	NULL
also	NULL
derived	NULL
from	NULL
B	NULL
cells	NULL
with	NULL
high	NULL
loads	NULL
of	NULL
somatic	NULL
mutations	NULL
and	NULL
thus	NULL
a	NULL
further	NULL
candidate	NULL
for	NULL
BCL-6	NULL
mutations	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
presence	NULL
and	NULL
potential	NULL
role	NULL
of	NULL
BCL-6	NULL
mutations	NULL
in	NULL
cHD	NULL
,	NULL
the	NULL
5'-noncoding	NULL
BCL-6	NULL
proportion	NULL
of	NULL
single	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
(	NULL
HRS	NULL
)	NULL
cells	NULL
from	NULL
6	NULL
cases	NULL
of	NULL
cHD	NULL
and	NULL
6	NULL
cases	NULL
of	NULL
HD-derived	NULL
cell	NULL
lines	NULL
was	NULL
analyzed	NULL
.	NULL

All	NULL
B-cell-derived	NULL
HD	NULL
cases	NULL
and	NULL
cell	NULL
lines	NULL
harbored	NULL
BCL-6	NULL
mutations	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
T-cell-derived	NULL
HD	NULL
cases	NULL
and	NULL
cell	NULL
lines	NULL
were	NULL
devoid	NULL
of	NULL
BCL-6	NULL
mutations	NULL
.	NULL

With	NULL
only	NULL
one	NULL
exception	NULL
,	NULL
there	NULL
were	NULL
no	NULL
lymphoma-specific	NULL
recurrent	NULL
BCL-6	NULL
mutations	NULL
detected	NULL
,	NULL
and	NULL
BCL-6	NULL
protein	NULL
was	NULL
absent	NULL
from	NULL
the	NULL
HRS	NULL
cells	NULL
of	NULL
most	NULL
cases	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
(	NULL
1	NULL
)	NULL
somatic	NULL
BCL-6	NULL
mutations	NULL
are	NULL
restricted	NULL
to	NULL
cHD	NULL
cases	NULL
of	NULL
B-cell	NULL
origin	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
the	NULL
BCL-6	NULL
mutations	NULL
represent	NULL
mostly	NULL
irrelevant	NULL
somatic	NULL
base	NULL
substitutions	NULL
without	NULL
consequences	NULL
for	NULL
BCL-6	NULL
protein	NULL
expression	NULL
and	NULL
the	NULL
pathogenesis	NULL
of	NULL
cHD	NULL
.	NULL

(	NULL
Blood	NULL
.	NULL

2001	NULL
;	NULL
97:2401-2405	NULL
)	NULL
Â©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
Introduction	NULL
The	NULL
proto-oncogene	NULL
BCL-6	NULL
is	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
genes	NULL
,	NULL
the	NULL
only	NULL
gene	NULL
that	NULL
is	NULL
known	NULL
to	NULL
be	NULL
significantly	NULL
somatically	NULL
mutated	NULL
in	NULL
the	NULL
course	NULL
of	NULL
the	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
reaction	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

*	NULL
These	NULL
somatic	NULL
mutations	NULL
occur	NULL
preferentially	NULL
in	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
somatic	NULL
hypermutations	NULL
,	NULL
as	NULL
well	NULL
as	NULL
translocations	NULL
,	NULL
in	NULL
the	NULL
BCL-6	NULL
regulatory	NULL
element	NULL
are	NULL
frequently	NULL
found	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
originating	NULL
from	NULL
GC	NULL
or	NULL
post-GC	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

It	NULL
is	NULL
postulated	NULL
that	NULL
these	NULL
alterations	NULL
affecting	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
several	NULL
lymphoma	NULL
entities	NULL
.	NULL
``	NULL

This	NULL
holds	NULL
especially	NULL
true	NULL
for	NULL
follicular	NULL
lymphoma	NULL
(	NULL
FL	NULL
)	NULL
and	NULL
diffuse	NULL
large	NULL
B-cell	NULL
lymphoma	NULL
(	NULL
DLBCL	NULL
)	NULL
,	NULL
which	NULL
harbor	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
their	NULL
highly	NULL
mutated	NULL
Ig	NULL
genes	NULL
,	NULL
alterations	NULL
in	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
.	NULL
``	NULL

''	NULL
The	NULL
tumor	NULL
cells	NULL
of	NULL
classical	NULL
Hodgkin	NULL
disease	NULL
(	NULL
cHD	NULL
)	NULL
,	NULL
the	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
(	NULL
HRS	NULL
)	NULL
cells	NULL
,	NULL
are	NULL
also	NULL
derived	NULL
from	NULL
highly	NULL
mutated	NULL
GC	NULL
or	NULL
post-GC	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
cases	NULL
.	NULL
``	NULL

''	NULL
Only	NULL
a	NULL
small	NULL
proportion	NULL
of	NULL
cases	NULL
originate	NULL
from	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
their	NULL
rearranged	NULL
TCR	NULL
genes	NULL
.	NULL
``	NULL

It	NULL
is	NULL
therefore	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
is	NULL
mutated	NULL
in	NULL
HRS	NULL
cells	NULL
and	NULL
,	NULL
comparable	NULL
to	NULL
the	NULL
situation	NULL
described	NULL
for	NULL
FL	NULL
and	NULL
DLBCL	NULL
,	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
cHD	NULL
.	NULL

However	NULL
,	NULL
BCL-6	NULL
is	NULL
expressed	NULL
in	NULL
only	NULL
a	NULL
proportion	NULL
of	NULL
cHD	NULL
cases	NULL
,	NULL
``	NULL
``	NULL
thereby	NULL
raising	NULL
the	NULL
question	NULL
of	NULL
the	NULL
significance	NULL
of	NULL
BCL-6	NULL
in	NULL
HD	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
see	NULL
whether	NULL
there	NULL
are	NULL
differences	NULL
in	NULL
the	NULL
mutational	NULL
pattern	NULL
of	NULL
BCL-6	NULL
in	NULL
HRS	NULL
cells	NULL
of	NULL
B-	NULL
or	NULL
T-cell	NULL
genotype	NULL
supporting	NULL
the	NULL
view	NULL
of	NULL
2	NULL
different	NULL
disease	NULL
entities	NULL
.	NULL

To	NULL
clarify	NULL
the	NULL
mutational	NULL
status	NULL
of	NULL
BCL-6	NULL
in	NULL
cHD	NULL
,	NULL
we	NULL
isolated	NULL
single	NULL
HRS	NULL
cells	NULL
from	NULL
6	NULL
patients	NULL
and	NULL
analyzed	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
.	NULL

Furthermore	NULL
,	NULL
nonneoplastic	NULL
cells	NULL
were	NULL
isolated	NULL
for	NULL
comparison	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
all	NULL
patients	NULL
with	NULL
cHD	NULL
with	NULL
a	NULL
B-cell	NULL
genotype	NULL
harbor	NULL
mutated	NULL
BCL-6	NULL
genes	NULL
,	NULL
whereas	NULL
patients	NULL
with	NULL
cHD	NULL
with	NULL
T-cell	NULL
genotype	NULL
lack	NULL
mutations	NULL
.	NULL

This	NULL
lends	NULL
further	NULL
credit	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
cHD	NULL
of	NULL
T-	NULL
and	NULL
B-cell	NULL
genotype	NULL
are	NULL
biological	NULL
distinct	NULL
entities	NULL
.	NULL

Material	NULL
and	NULL
methods	NULL
Tissue	NULL
samples	NULL
,	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
immunostaining	NULL
From	NULL
a	NULL
series	NULL
of	NULL
cHD	NULL
cases	NULL
from	NULL
the	NULL
files	NULL
of	NULL
the	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
,	NULL
we	NULL
selected	NULL
6	NULL
cases	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
patients	NULL
displayed	NULL
a	NULL
T-cell	NULL
genotype	NULL
,	NULL
and	NULL
4	NULL
patients	NULL
displayed	NULL
a	NULL
B-cell	NULL
genotype	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
6	NULL
HD-derived	NULL
cell	NULL
lines	NULL
(	NULL
L428	NULL
,	NULL
KMH2	NULL
,	NULL
L591	NULL
,	NULL
L1236	NULL
,	NULL
L540	NULL
,	NULL
and	NULL
Holden	NULL
)	NULL
were	NULL
included	NULL
in	NULL
this	NULL
study	NULL
.	NULL

DNA	NULL
extraction	NULL
High	NULL
molecular	NULL
weight	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
5.0	NULL
X	NULL
105	NULL
cell	NULL
line	NULL
cells	NULL
employing	NULL
the	NULL
QIAamp	NULL
Tissue	NULL
Kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Hilden	NULL
,	NULL
Germany	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

DNA	NULL
was	NULL
dissolved	NULL
in	NULL
100	NULL
uL	NULL
distilled	NULL
water	NULL
,	NULL
quantified	NULL
photometrically	NULL
,	NULL
and	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
.	NULL

From	NULL
the	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
Consultation	NULL
and	NULL
Reference	NULL
Center	NULL
for	NULL
Lymph	NULL
Node	NULL
Pathology	NULL
and	NULL
Haematopathology	NULL
,	NULL
University	NULL
Hospital	NULL
Benjamin	NULL
Franklin	NULL
,	NULL
Free	NULL
University	NULL
Berlin	NULL
,	NULL
Germany	NULL
.	NULL

Submitted	NULL
July	NULL
31	NULL
,	NULL
2000	NULL
;	NULL
accepted	NULL
November	NULL
13	NULL
,	NULL
2000	NULL
.	NULL

Sponsored	NULL
by	NULL
a	NULL
grant	NULL
(	NULL
70-2202-M03	NULL
)	NULL
from	NULL
Deutsche	NULL
Krebshilfe	NULL
,	NULL
Bonn	NULL
,	NULL
Germany	NULL
,	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
(	NULL
9917155	NULL
)	NULL
from	NULL
Berliner	NULL
Krebsgesellschaft	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
Â«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
Reprints	NULL
:	NULL
Harald	NULL
Stein	NULL
,	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
Hospital	NULL
Benjamin	NULL
Franklin	NULL
,	NULL
Free	NULL
University	NULL
Berlin	NULL
,	NULL
Hindenburgdamm	NULL
30	NULL
,	NULL
12200	NULL
Berlin	NULL
,	NULL
Germany	NULL
;	NULL
e-mail	NULL
:	NULL
stein	NULL
@	NULL
medizin.fu-berlin.de	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

Therefore	NULL
,	NULL
and	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
,	NULL
this	NULL
article	NULL
is	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
.	NULL

Â©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
2401	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

2402	NULL
-	NULL
SETZ	NULL
etal	NULL
For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
Â«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
Table	NULL
1	NULL
.	NULL

Genotype	NULL
and	NULL
immunophenotype	NULL
of	NULL
the	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
Patient	NULL
no	NULL
.	NULL

Age	NULL
,	NULL
y/sex	NULL
Genotype	NULL
CD30	NULL
CD15	NULL
CD20	NULL
CD3	NULL
CD8	NULL
Perforin	NULL
EBV	NULL
LMP-1	NULL
1	NULL
56/M	NULL
T	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
2	NULL
72/M	NULL
T	NULL
+	NULL
+	NULL
-	NULL
-/+	NULL
-/+	NULL
+	NULL
3	NULL
NA	NULL
B	NULL
+	NULL
+	NULL
-	NULL
-/+	NULL
-	NULL
-	NULL
4	NULL
34/M	NULL
B	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
-	NULL
5	NULL
35/M	NULL
B	NULL
+	NULL
+	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
6	NULL
31/F	NULL
B	NULL
+	NULL
+	NULL
-	NULL
+/-	NULL
-	NULL
-	NULL
EBV	NULL
indicates	NULL
Epstein-Barr	NULL
virus	NULL
;	NULL
T	NULL
,	NULL
T	NULL
cell	NULL
;	NULL
B	NULL
,	NULL
B	NULL
cell	NULL
;	NULL
NA	NULL
,	NULL
not	NULL
available	NULL
;	NULL
+	NULL
,	NULL
positive	NULL
;	NULL
-	NULL
,	NULL
negative	NULL
;	NULL
+/-	NULL
,	NULL
more	NULL
than	NULL
50	NULL
%	NULL
positive	NULL
;	NULL
-/+	NULL
,	NULL
more	NULL
than	NULL
50	NULL
%	NULL
negative	NULL
.	NULL

Immunohistochemistry	NULL
Both	NULL
lymph	NULL
node	NULL
biopsies	NULL
and	NULL
HD-derived	NULL
cell	NULL
lines	NULL
were	NULL
immunohisto-chemically	NULL
analyzed	NULL
by	NULL
a	NULL
panel	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
CD30	NULL
(	NULL
Ber-H2	NULL
)	NULL
,	NULL
CD15	NULL
(	NULL
C3D1	NULL
)	NULL
,	NULL
LMP-1	NULL
(	NULL
CS1-4	NULL
)	NULL
,	NULL
CD20	NULL
(	NULL
L26	NULL
)	NULL
,	NULL
BCL-6	NULL
(	NULL
594	NULL
)	NULL
,	NULL
CD3	NULL
(	NULL
UCHT1	NULL
)	NULL
,	NULL
CD8	NULL
(	NULL
C8/144B	NULL
)	NULL
(	NULL
all	NULL
from	NULL
Dako	NULL
Diagnostics	NULL
,	NULL
Hamburg	NULL
,	NULL
Ger-many	NULL
)	NULL
,	NULL
and	NULL
perforin	NULL
(	NULL
P1-8	NULL
)	NULL
(	NULL
Kamiya	NULL
Biomedical	NULL
Company	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Immunostaining	NULL
was	NULL
performed	NULL
on	NULL
frozen	NULL
or	NULL
formalin-fixed	NULL
,	NULL
paraffin-embedded	NULL
sections	NULL
employing	NULL
the	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
antialkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
technique	NULL
.	NULL

'*	NULL
Paraffin-embedded	NULL
sections	NULL
were	NULL
pre-treated	NULL
by	NULL
pressure	NULL
cooking	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

''	NULL
Single	NULL
cell	NULL
isolation	NULL
Using	NULL
a	NULL
hydraulic	NULL
micromanipulation	NULL
device	NULL
,	NULL
CD30+Â®	NULL
HRS	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
immunostained	NULL
frozen	NULL
tissue	NULL
sections	NULL
from	NULL
6	NULL
patients	NULL
with	NULL
cHD	NULL
.	NULL
'	NULL

We	NULL
pooled	NULL
2-7	NULL
single	NULL
HRS	NULL
cells	NULL
to	NULL
obtain	NULL
higher	NULL
PCR	NULL
amplification	NULL
rates	NULL
.	NULL

All	NULL
cases	NULL
were	NULL
analyzed	NULL
at	NULL
least	NULL
twice	NULL
in	NULL
completely	NULL
independent	NULL
cell	NULL
isolation	NULL
procedures	NULL
and	NULL
PCR	NULL
assays	NULL
.	NULL

In	NULL
cases	NULL
with	NULL
mutated	NULL
BCL-6	NULL
5'-noncoding	NULL
sequences	NULL
in	NULL
the	NULL
HRS	NULL
cells	NULL
(	NULL
reference	NULL
sequence	NULL
AF191831	NULL
)	NULL
,	NULL
``	NULL
additional	NULL
CD30~	NULL
reactive	NULL
cells	NULL
were	NULL
investigated	NULL
to	NULL
rule	NULL
out	NULL
individual	NULL
polymorphism	NULL
.	NULL

Furthermore	NULL
,	NULL
buffers	NULL
overlaying	NULL
the	NULL
tissue	NULL
sections	NULL
during	NULL
the	NULL
cell	NULL
isolation	NULL
process	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
.	NULL

PCR	NULL
Isolated	NULL
cells	NULL
were	NULL
digested	NULL
with	NULL
0.1	NULL
mg/mL	NULL
proteinase	NULL
K	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
50Â°C	NULL
and	NULL
,	NULL
after	NULL
heat	NULL
denaturation	NULL
of	NULL
the	NULL
enzyme	NULL
,	NULL
subjected	NULL
to	NULL
a	NULL
seminested	NULL
BCL-6	NULL
PCR	NULL
.	NULL

The	NULL
PCR	NULL
was	NULL
carried	NULL
with	NULL
Tag	NULL
buffer	NULL
(	NULL
PerkinElmer	NULL
)	NULL
supplemented	NULL
with	NULL
1.5	NULL
mM	NULL
magnesium	NULL
dichloride	NULL
(	NULL
MgCl	NULL
)	NULL
,	NULL
0.8	NULL
mM	NULL
dNTP	NULL
(	NULL
deoxynucleoside-5'-triphosphate	NULL
)	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
each	NULL
primer	NULL
,	NULL
and	NULL
2	NULL
U	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
PerkinElmer	NULL
)	NULL
.	NULL

The	NULL
first	NULL
round	NULL
of	NULL
amplification	NULL
was	NULL
performed	NULL
employing	NULL
belÃ©up	NULL
(	NULL
5'-ATG	NULL
CTT	NULL
TGG	NULL
CTC	NULL
CAA	NULL
GTT-3	NULL
'	NULL
)	NULL
and	NULL
belÃ©low	NULL
(	NULL
5'-CAC	NULL
GAT	NULL
ACT	NULL
TCA	NULL
TCT	NULL
CAT	NULL
C-3	NULL
'	NULL
)	NULL
.	NULL

For	NULL
re-amplification	NULL
the	NULL
belÃ©low	NULL
primer	NULL
was	NULL
replaced	NULL
by	NULL
a	NULL
nested	NULL
belÃ©low2	NULL
primer	NULL
(	NULL
5-CGG	NULL
CTC	NULL
GAA	NULL
GGC	NULL
AGG-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
conditions	NULL
were	NULL
96Â°C	NULL
for	NULL
15	NULL
seconds	NULL
,	NULL
62Â°C	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
and	NULL
72Â°C	NULL
for	NULL
50	NULL
seconds	NULL
for	NULL
the	NULL
initial	NULL
5	NULL
cycles	NULL
.	NULL

For	NULL
the	NULL
remaining	NULL
35	NULL
cycles	NULL
the	NULL
annealing	NULL
conditions	NULL
were	NULL
reduced	NULL
to	NULL
60Â°C	NULL
for	NULL
30	NULL
seconds	NULL
.	NULL

The	NULL
re-amplification	NULL
was	NULL
carried	NULL
out	NULL
under	NULL
the	NULL
same	NULL
PCR	NULL
conditions	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
10	NULL
initial	NULL
cycles	NULL
of	NULL
higher	NULL
stringency	NULL
instead	NULL
of	NULL
5	NULL
cycles	NULL
.	NULL

Negative	NULL
and	NULL
positive	NULL
controls	NULL
for	NULL
single	NULL
cell	NULL
analysis	NULL
were	NULL
performed	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
whereas	NULL
400	NULL
ng	NULL
cell	NULL
line	NULL
DNA	NULL
was	NULL
amplified	NULL
by	NULL
only	NULL
one	NULL
round	NULL
of	NULL
PCR	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
analyzed	NULL
on	NULL
1.5	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Bands	NULL
of	NULL
appropriate	NULL
size	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gels	NULL
and	NULL
purified	NULL
with	NULL
the	NULL
Qiaex-2	NULL
DNA	NULL
isolation	NULL
kit	NULL
(	NULL
Qiagen	NULL
)	NULL
.	NULL

Cloning	NULL
and	NULL
sequencing	NULL
of	NULL
PCR	NULL
products	NULL
Purified	NULL
PCR	NULL
products	NULL
obtained	NULL
from	NULL
B-cell-derived	NULL
HD	NULL
cell	NULL
lines	NULL
were	NULL
cloned	NULL
(	NULL
Topo	NULL
cloning	NULL
,	NULL
Invitrogen	NULL
,	NULL
Westbrook	NULL
,	NULL
ME	NULL
)	NULL
,	NULL
and	NULL
10-20	NULL
randomly	NULL
selected	NULL
colonies	NULL
were	NULL
sequenced	NULL
by	NULL
fluorescence	NULL
chain	NULL
termination	NULL
technique	NULL
(	NULL
Bigdye	NULL
;	NULL
ABI	NULL
,	NULL
Weiterstadt	NULL
,	NULL
Germany	NULL
)	NULL
on	NULL
an	NULL
automated	NULL
sequencer	NULL
(	NULL
ABI	NULL
377A	NULL
,	NULL
ABI	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
sequences	NULL
were	NULL
compared	NULL
to	NULL
published	NULL
data	NULL
bank	NULL
sequences	NULL
(	NULL
GenBank	NULL
)	NULL
and	NULL
our	NULL
own	NULL
unpublished	NULL
sequences	NULL
.	NULL

Results	NULL
Genotype	NULL
and	NULL
immunophenotype	NULL
of	NULL
the	NULL
HRS	NULL
cells	NULL
The	NULL
genotype	NULL
and	NULL
expression	NULL
profile	NULL
of	NULL
the	NULL
6	NULL
cHD	NULL
cases	NULL
used	NULL
for	NULL
the	NULL
present	NULL
study	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
.	NULL
``	NULL

In	NULL
brief	NULL
,	NULL
the	NULL
HRS	NULL
cells	NULL
of	NULL
4	NULL
cases	NULL
harbored	NULL
highly	NULL
mutated	NULL
rearranged	NULL
IgH	NULL
genes	NULL
,	NULL
whereas	NULL
the	NULL
other	NULL
2	NULL
cases	NULL
displayed	NULL
HRS	NULL
cells	NULL
with	NULL
clonal	NULL
TCR	NULL
Both	NULL
cases	NULL
with	NULL
rearranged	NULL
TCR	NULL
genes	NULL
displayed	NULL
a	NULL
strong	NULL
expression	NULL
of	NULL
perforin	NULL
in	NULL
all	NULL
tumor	NULL
cells	NULL
.	NULL

One	NULL
of	NULL
the	NULL
cases	NULL
with	NULL
a	NULL
B-cell	NULL
genotype	NULL
(	NULL
patient	NULL
no	NULL
.	NULL

5	NULL
)	NULL
was	NULL
positive	NULL
for	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-encoded	NULL
LMP-1	NULL
protein	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
BCL-6	NULL
was	NULL
heterogeneous	NULL
among	NULL
the	NULL
cases	NULL
and	NULL
cell	NULL
lines	NULL
investigated	NULL
.	NULL

Two	NULL
cHD	NULL
cases	NULL
(	NULL
one	NULL
case	NULL
with	NULL
TCR	NULL
rearrangement	NULL
and	NULL
one	NULL
with	NULL
Ig	NULL
H	NULL
rearrangement	NULL
)	NULL
disclosed	NULL
a	NULL
BCL-6	NULL
expression	NULL
of	NULL
virtually	NULL
all	NULL
HRS	NULL
cells	NULL
,	NULL
whereas	NULL
BCL-6	NULL
was	NULL
completely	NULL
absent	NULL
in	NULL
the	NULL
HRS	NULL
cells	NULL
of	NULL
2	NULL
further	NULL
cases	NULL
(	NULL
both	NULL
with	NULL
IgH	NULL
rearrangement	NULL
)	NULL
.	NULL

In	NULL
the	NULL
remaining	NULL
2	NULL
cases	NULL
,	NULL
scattered	NULL
HRS	NULL
cells	NULL
were	NULL
BCL-6+*	NULL
.	NULL

Imunostaining	NULL
of	NULL
HD-derived	NULL
cell	NULL
lines	NULL
for	NULL
BCL-6	NULL
revealed	NULL
single	NULL
BCL-6*	NULL
cells	NULL
in	NULL
cell	NULL
lines	NULL
L1236	NULL
,	NULL
L428	NULL
,	NULL
KMH2	NULL
,	NULL
and	NULL
Holden	NULL
.	NULL

Up	NULL
to	NULL
10	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
positive	NULL
only	NULL
in	NULL
cell	NULL
lines	NULL
L540	NULL
and	NULL
L591	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

BCL-6	NULL
sequence	NULL
analysis	NULL
in	NULL
single	NULL
cells	NULL
and	NULL
cell	NULL
lines	NULL
For	NULL
analysis	NULL
of	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
,	NULL
202	NULL
single	NULL
HRS	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
6	NULL
cases	NULL
of	NULL
cHD	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Table	NULL
2	NULL
.	NULL

Somatic	NULL
BCL-6	NULL
and	NULL
igH	NULL
mutations	NULL
and	NULL
expression	NULL
of	NULL
BCL-6	NULL
protein	NULL
BCL-6	NULL
IgH	NULL
somatic	NULL
Ig	NULL
coding	NULL
BCL-6	NULL
somatic	NULL
protein	NULL
mutations	NULL
capacity	NULL
mutations	NULL
expression	NULL
Patient	NULL
no	NULL
.	NULL

1	NULL
NC	NULL
NC	NULL
0	NULL
S	NULL
2	NULL
NC	NULL
NC	NULL
0	NULL
+	NULL
3	NULL
17	NULL
+	NULL
3	NULL
4	NULL
24	NULL
+	NULL
3	NULL
5	NULL
14	NULL
+	NULL
2	NULL
S	NULL
6	NULL
29	NULL
-	NULL
1	NULL
+	NULL
Cell	NULL
line	NULL
L540	NULL
NC	NULL
NC	NULL
0	NULL
-/+	NULL
Holden	NULL
NC	NULL
NC	NULL
0	NULL
S	NULL
L1236	NULL
30*	NULL
+4	NULL
8/15/8+	NULL
S	NULL
KMH2	NULL
26	NULL
+	NULL
1	NULL
S	NULL
L428	NULL
20	NULL
+	NULL
2/8t	NULL
S	NULL
L591	NULL
26	NULL
-	NULL
1/0Â¢	NULL
-/+	NULL
The	NULL
BCL-6	NULL
somatic	NULL
mutations	NULL
are	NULL
in	NULL
the	NULL
5'-noncoding	NULL
region	NULL
.	NULL

NC	NULL
indicates	NULL
not	NULL
calculable	NULL
due	NULL
to	NULL
absence	NULL
of	NULL
ig	NULL
rearrangements	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
rearranged	NULL
TCR	NULL
genes	NULL
;	NULL
S	NULL
,	NULL
single	NULL
cells	NULL
;	NULL
-/+	NULL
,	NULL
5	NULL
%	NULL
to	NULL
10	NULL
%	NULL
;	NULL
+	NULL
,	NULL
90	NULL
%	NULL
to	NULL
100	NULL
%	NULL
;	NULL
-	NULL
,	NULL
negative	NULL
.	NULL

*Refers	NULL
to	NULL
the	NULL
functional	NULL
igH	NULL
coding	NULL
region	NULL
.	NULL

tindicates	NULL
the	NULL
number	NULL
of	NULL
BCL-6	NULL
mutations	NULL
on	NULL
the	NULL
different	NULL
alleles	NULL
.	NULL

Note	NULL
:	NULL
L1236	NULL
harbor	NULL
3	NULL
alleles	NULL
of	NULL
be16	NULL
.	NULL
``	NULL

''	NULL
base	NULL
substitution	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
(	NULL
Octamer	NULL
binding	NULL
site	NULL
)	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
Â«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
BCL-6	NULL
MUTATIONS	NULL
IN	NULL
eHD	NULL
OF	NULL
B-	NULL
AND	NULL
TYPE	NULL
_	NULL
2403	NULL
Table	NULL
3	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
5'-noncoding	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
cHD	NULL
of	NULL
the	NULL
T-	NULL
and	NULL
B-cell	NULL
genotype	NULL
HRS	NULL
cells	NULL
Reactive	NULL
cells	NULL
Cells	NULL
Nucleotide	NULL
Patient	NULL
Genotype	NULL
studied	NULL
Mutated/unmutated	NULL
changes	NULL
Cells	NULL
studied	NULL
Identical/nonidentical	NULL
1	NULL
T	NULL
19	NULL
0/5	NULL
None	NULL
NA	NULL
NA	NULL
2	NULL
T	NULL
30	NULL
O/7	NULL
None	NULL
NA	NULL
NA	NULL
3	NULL
B	NULL
42	NULL
30	NULL
99A	NULL
>	NULL
C	NULL
25	NULL
0/3	NULL
122G	NULL
>	NULL
C*	NULL
448G	NULL
>	NULL
C	NULL
4	NULL
B	NULL
50	NULL
2/4	NULL
202A	NULL
>	NULL
C	NULL
16	NULL
0/2t	NULL
284A	NULL
>	NULL
G	NULL
300G	NULL
>	NULL
C	NULL
397G	NULL
>	NULL
C	NULL
5	NULL
B	NULL
42	NULL
3/71	NULL
311A	NULL
>	NULL
C	NULL
70	NULL
0/6	NULL
518delG	NULL
6	NULL
B	NULL
19	NULL
4/1	NULL
520delT	NULL
61	NULL
0/5	NULL
Reference	NULL
sequence	NULL
corresponds	NULL
to	NULL
AF191831	NULL
.	NULL
``	NULL

Identical/nonidentical	NULL
indicates	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
BCL-6	NULL
mutations	NULL
observed	NULL
in	NULL
reactive	NULL
cells	NULL
with	NULL
those	NULL
in	NULL
HRS	NULL
cells	NULL
.	NULL

Mutations	NULL
reported	NULL
as	NULL
recurrent	NULL
in	NULL
FL	NULL
and	NULL
DLBCLS	NULL
are	NULL
in	NULL
bold	NULL
,	NULL
and	NULL
the	NULL
polymorphism	NULL
at	NULL
position	NULL
397	NULL
(	NULL
397G	NULL
>	NULL
CJ	NULL
is	NULL
in	NULL
italics	NULL
.	NULL

Del	NULL
indicates	NULL
deletion	NULL
;	NULL
NA	NULL
,	NULL
not	NULL
analyzed	NULL
.	NULL

*Indicates	NULL
mutation	NULL
in	NULL
a	NULL
RGWY	NULL
motif	NULL
.	NULL
``	NULL

{	NULL
The	NULL
2	NULL
sequences	NULL
represent	NULL
both	NULL
alleles	NULL
because	NULL
only	NULL
one	NULL
of	NULL
the	NULL
2	NULL
sequences	NULL
has	NULL
the	NULL
polymorphism	NULL
at	NULL
position	NULL
397	NULL
(	NULL
397G	NULL
>	NULL
C	NULL
)	NULL
.5	NULL
172	NULL
single	NULL
â¬CD30~	NULL
reactive	NULL
lymphoid	NULL
cells	NULL
were	NULL
extracted	NULL
from	NULL
the	NULL
same	NULL
tissue	NULL
specimens	NULL
to	NULL
determine	NULL
irrelevant	NULL
individual	NULL
polymorphism	NULL
.	NULL

Furthermore	NULL
,	NULL
6	NULL
HD-derived	NULL
cell	NULL
lines	NULL
were	NULL
included	NULL
in	NULL
this	NULL
study	NULL
.	NULL

From	NULL
each	NULL
cell	NULL
line	NULL
,	NULL
5-18	NULL
sequences	NULL
were	NULL
analyzed	NULL
by	NULL
cloning	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
.	NULL

Only	NULL
base	NULL
substitutions	NULL
that	NULL
were	NULL
repeatedly	NULL
found	NULL
in	NULL
completely	NULL
independent	NULL
analyses	NULL
were	NULL
considered	NULL
as	NULL
real	NULL
mutations	NULL
.	NULL

Unique	NULL
alterations	NULL
were	NULL
regarded	NULL
as	NULL
errors	NULL
of	NULL
the	NULL
Taq	NULL
polymerase	NULL
.	NULL

The	NULL
BCL-6	NULL
sequences	NULL
of	NULL
all	NULL
4	NULL
B-cell-derived	NULL
HD	NULL
cases	NULL
and	NULL
the	NULL
4	NULL
B-cell-derived	NULL
HD	NULL
cell	NULL
lines	NULL
carried	NULL
1-15	NULL
somatic	NULL
alterations	NULL
(	NULL
Tables	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Approximately	NULL
half	NULL
of	NULL
these	NULL
mutations	NULL
represented	NULL
transitions	NULL
,	NULL
whereas	NULL
the	NULL
remaining	NULL
half	NULL
represented	NULL
transversions	NULL
.	NULL

The	NULL
base	NULL
substitutions	NULL
observed	NULL
in	NULL
the	NULL
CD30+	NULL
HRS	NULL
cells	NULL
were	NULL
not	NULL
detectable	NULL
in	NULL
CD30~	NULL
reactive	NULL
cells	NULL
isolated	NULL
from	NULL
the	NULL
same	NULL
tissue	NULL
sections	NULL
.	NULL

This	NULL
clearly	NULL
indicates	NULL
that	NULL
Table	NULL
4	NULL
.	NULL

Characteristic	NULL
changes	NULL
in	NULL
the	NULL
5'-noncoding	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
Hodgkin	NULL
disease	NULL
cell	NULL
lines	NULL
Cell	NULL
line	NULL
Genotype	NULL
Nucleotide	NULL
changes	NULL
L540*	NULL
T	NULL
None	NULL
Holden	NULL
T	NULL
None	NULL
KMH2*	NULL
B	NULL
(	NULL
a	NULL
)	NULL
607G	NULL
>	NULL
A	NULL
L428*	NULL
B	NULL
(	NULL
a	NULL
)	NULL
201T	NULL
>	NULL
G	NULL
,	NULL
246T	NULL
>	NULL
C	NULL
(	NULL
b	NULL
)	NULL
82G	NULL
>	NULL
A	NULL
,	NULL
92T	NULL
>	NULL
A	NULL
,	NULL
1190	NULL
>	NULL
T	NULL
,	NULL
290T	NULL
>	NULL
C	NULL
,	NULL
301A	NULL
>	NULL
G	NULL
,	NULL
337A	NULL
>	NULL
C	NULL
,	NULL
445A	NULL
>	NULL
T	NULL
,	NULL
484T	NULL
>	NULL
C	NULL
L591	NULL
B	NULL
(	NULL
a	NULL
)	NULL
122G	NULL
>	NULL
Ct	NULL
(	NULL
b	NULL
)	NULL
None	NULL
L1236+	NULL
B	NULL
(	NULL
a	NULL
)	NULL
123C	NULL
>	NULL
Gt	NULL
,	NULL
220G	NULL
>	NULL
C	NULL
,	NULL
299G	NULL
>	NULL
A	NULL
,	NULL
390A	NULL
>	NULL
C	NULL
,	NULL
435C	NULL
>	NULL
T	NULL
,	NULL
437G	NULL
>	NULL
AÂ§	NULL
,	NULL
506delA	NULL
,	NULL
580C	NULL
>	NULL
G	NULL
(	NULL
b	NULL
)	NULL
181A	NULL
>	NULL
G	NULL
,	NULL
235T	NULL
>	NULL
C	NULL
,	NULL
279delT	NULL
,	NULL
314A	NULL
>	NULL
T	NULL
,	NULL
327A	NULL
>	NULL
G	NULL
,	NULL
328G	NULL
>	NULL
T	NULL
,	NULL
377G	NULL
>	NULL
GC	NULL
,	NULL
4271	NULL
>	NULL
A	NULL
,	NULL
445A	NULL
>	NULL
C	NULL
,	NULL
498G	NULL
>	NULL
C	NULL
,	NULL
5100	NULL
>	NULL
T	NULL
,	NULL
518G	NULL
>	NULL
A	NULL
,	NULL
541T	NULL
>	NULL
A	NULL
,	NULL
5430C	NULL
>	NULL
G	NULL
,	NULL
569T	NULL
>	NULL
G	NULL
(	NULL
c	NULL
)	NULL
181A	NULL
>	NULL
G	NULL
,	NULL
220G	NULL
>	NULL
C	NULL
,	NULL
299G	NULL
>	NULL
A	NULL
,	NULL
390A	NULL
>	NULL
C	NULL
,	NULL
435C	NULL
>	NULL
T	NULL
,	NULL
437G	NULL
>	NULL
AÂ§	NULL
,	NULL
506delA	NULL
,	NULL
5800	NULL
>	NULL
G	NULL
Reference	NULL
sequence	NULL
corresponds	NULL
to	NULL
AF191831	NULL
.	NULL
``	NULL

If	NULL
different	NULL
alleles	NULL
were	NULL
detected	NULL
,	NULL
they	NULL
are	NULL
marked	NULL
with	NULL
(	NULL
a	NULL
)	NULL
,	NULL
(	NULL
b	NULL
)	NULL
,	NULL
or	NULL
(	NULL
c	NULL
)	NULL
.	NULL

Mutations	NULL
reported	NULL
as	NULL
recurrent	NULL
in	NULL
FL	NULL
and	NULL
DLBCLÂ®	NULL
are	NULL
in	NULL
bold	NULL
.	NULL

*The	NULL
same	NULL
results	NULL
have	NULL
already	NULL
been	NULL
described	NULL
in	NULL
Carbone	NULL
et	NULL
al	NULL
.	NULL
'	NULL

''	NULL
In	NULL
addition	NULL
,	NULL
mutation	NULL
445A	NULL
>	NULL
T	NULL
was	NULL
found	NULL
in	NULL
cell	NULL
line	NULL
L428	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
discriminate	NULL
both	NULL
alleles	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

{	NULL
Mutation	NULL
is	NULL
located	NULL
at	NULL
an	NULL
RGWY	NULL
motif	NULL
.	NULL
``	NULL

$	NULL
The	NULL
presence	NULL
of	NULL
3	NULL
alleles	NULL
in	NULL
cell	NULL
line	NULL
L1236	NULL
is	NULL
in	NULL
harmony	NULL
with	NULL
its	NULL
karyotype	NULL
.	NULL
``	NULL

''	NULL
Â§Site	NULL
of	NULL
mutation	NULL
also	NULL
described	NULL
in	NULL
reactive	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

the	NULL
BCL-6	NULL
mutations	NULL
observed	NULL
in	NULL
HRS	NULL
cells	NULL
are	NULL
somatic	NULL
and	NULL
were	NULL
most	NULL
likely	NULL
introduced	NULL
in	NULL
the	NULL
course	NULL
of	NULL
the	NULL
GC	NULL
reaction	NULL
.	NULL

Most	NULL
of	NULL
these	NULL
mutations	NULL
are	NULL
new	NULL
and	NULL
are	NULL
not	NULL
yet	NULL
described	NULL
elsewhere	NULL
.	NULL

The	NULL
remaining	NULL
4	NULL
mutations	NULL
were	NULL
recurrent	NULL
.	NULL
``	NULL

However	NULL
,	NULL
2	NULL
of	NULL
these	NULL
mutations	NULL
were	NULL
located	NULL
in	NULL
a	NULL
RGWY	NULL
mutation	NULL
hotspot	NULL
,	NULL
``	NULL
and	NULL
another	NULL
one	NULL
occurred	NULL
at	NULL
a	NULL
site	NULL
that	NULL
was	NULL
also	NULL
reported	NULL
to	NULL
be	NULL
mutated	NULL
in	NULL
reactive	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
3	NULL
of	NULL
4	NULL
recurrent	NULL
mutations	NULL
do	NULL
not	NULL
represent	NULL
lymphoma-specific	NULL
base	NULL
substitutions	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
B-cell-derived	NULL
cHD	NULL
cases	NULL
and	NULL
cell	NULL
lines	NULL
,	NULL
both	NULL
cHD	NULL
cases	NULL
with	NULL
T-cell	NULL
genotype	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
2	NULL
T-cell-derived	NULL
HD	NULL
cell	NULL
lines	NULL
,	NULL
were	NULL
unmutated	NULL
(	NULL
Tables	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
of	NULL
GC	NULL
T	NULL
cells	NULL
could	NULL
be	NULL
affected	NULL
by	NULL
the	NULL
somatic	NULL
hypermutation	NULL
machinery	NULL
,	NULL
we	NULL
isolated	NULL
29	NULL
GC	NULL
T	NULL
cells	NULL
identified	NULL
by	NULL
their	NULL
B-F1	NULL
positivity	NULL
.	NULL

The	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
resulting	NULL
BCL-6	NULL
PCR	NULL
products	NULL
disclosed	NULL
that	NULL
none	NULL
of	NULL
these	NULL
cells	NULL
displayed	NULL
somatic	NULL
mutations	NULL
introduced	NULL
in	NULL
the	NULL
GC	NULL
environment	NULL
.	NULL

Correlation	NULL
of	NULL
the	NULL
somatic	NULL
igH	NULL
and	NULL
BCL-6	NULL
mutations	NULL
and	NULL
BCL-6	NULL
protein	NULL
expression	NULL
We	NULL
compared	NULL
the	NULL
frequency	NULL
of	NULL
somatic	NULL
mutations	NULL
found	NULL
in	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
with	NULL
those	NULL
published	NULL
for	NULL
the	NULL
IgH	NULL
genes	NULL
in	NULL
corresponding	NULL
cases	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL
'	NULL

>	NULL
``	NULL
``	NULL
Although	NULL
all	NULL
cases	NULL
with	NULL
IgH	NULL
mutations	NULL
displayed	NULL
BCL-6	NULL
mutations	NULL
,	NULL
there	NULL
was	NULL
no	NULL
correlation	NULL
in	NULL
the	NULL
number	NULL
of	NULL
mutations	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
was	NULL
no	NULL
correlation	NULL
between	NULL
the	NULL
number	NULL
of	NULL
BCL-6	NULL
mutations	NULL
and	NULL
the	NULL
BCL-6	NULL
expression	NULL
.	NULL

Discussion	NULL
Previous	NULL
studies	NULL
have	NULL
shown	NULL
a	NULL
correlation	NULL
between	NULL
the	NULL
appearance	NULL
of	NULL
somatic	NULL
hypermutations	NULL
in	NULL
the	NULL
Ig	NULL
genes	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
.	NULL
``	NULL

''	NULL
``	NULL
Consequently	NULL
,	NULL
this	NULL
correlation	NULL
can	NULL
also	NULL
be	NULL
observed	NULL
in	NULL
B-cell	NULL
non-Hodgkin	NULL
lymphoma	NULL
(	NULL
NHL	NULL
)	NULL
,	NULL
such	NULL
as	NULL
FL	NULL
and	NULL
DLBCL	NULL
,	NULL
which	NULL
carry	NULL
high	NULL
loads	NULL
of	NULL
mutations	NULL
in	NULL
their	NULL
Ig	NULL
genes	NULL
.	NULL
``	NULL

''	NULL
The	NULL
precise	NULL
role	NULL
of	NULL
BCL-6	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
the	NULL
NHL	NULL
is	NULL
,	NULL
however	NULL
,	NULL
not	NULL
yet	NULL
clear	NULL
.	NULL

CHD	NULL
represents	NULL
a	NULL
lymphoma	NULL
entity	NULL
that	NULL
is	NULL
derived	NULL
from	NULL
B	NULL
cells	NULL
with	NULL
highly	NULL
mutated	NULL
Ig	NULL
genes	NULL
in	NULL
most	NULL
instances	NULL
(	NULL
approximately	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2404	NULL
_	NULL
SETZ	NULL
etal	NULL
98	NULL
%	NULL
)	NULL
and	NULL
from	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
few	NULL
cases	NULL
(	NULL
approximately	NULL
2	NULL
%	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
B-cell-derived	NULL
cHD	NULL
cases	NULL
,	NULL
as	NULL
well	NULL
as	NULL
T-cell-derived	NULL
cHD	NULL
cases	NULL
,	NULL
carry	NULL
mutations	NULL
in	NULL
their	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
,	NULL
we	NULL
isolated	NULL
202	NULL
single	NULL
HRS	NULL
cells	NULL
from	NULL
6	NULL
patients	NULL
with	NULL
cHD	NULL
.	NULL

Four	NULL
of	NULL
these	NULL
patients	NULL
harbored	NULL
HRS	NULL
cells	NULL
of	NULL
B-cell	NULL
genotype	NULL
,	NULL
whereas	NULL
2	NULL
further	NULL
patients	NULL
harbored	NULL
HRS	NULL
cells	NULL
of	NULL
T-cell	NULL
genotype	NULL
.	NULL
``	NULL

For	NULL
comparison	NULL
,	NULL
6	NULL
HD	NULL
cell	NULL
lines	NULL
(	NULL
4	NULL
with	NULL
B-cell	NULL
genotype	NULL
and	NULL
2	NULL
with	NULL
T-cell	NULL
genotype	NULL
)	NULL
were	NULL
included	NULL
in	NULL
this	NULL
study	NULL
,	NULL
and	NULL
201	NULL
single	NULL
reactive	NULL
cells	NULL
were	NULL
analyzed	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
were	NULL
equivocal	NULL
in	NULL
that	NULL
all	NULL
patients	NULL
with	NULL
B-cell-derived	NULL
HD	NULL
and	NULL
HD	NULL
cell	NULL
lines	NULL
of	NULL
B-cell	NULL
type	NULL
were	NULL
found	NULL
to	NULL
carry	NULL
somatic	NULL
BCL-6	NULL
mutations	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
patients	NULL
with	NULL
T-cell-derived	NULL
HD	NULL
and	NULL
cell	NULL
lines	NULL
were	NULL
devoid	NULL
of	NULL
base	NULL
substitutions	NULL
in	NULL
the	NULL
BCL-6	NULL
gene	NULL
as	NULL
well	NULL
as	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
the	NULL
GC	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
reactive	NULL
GC	NULL
T	NULL
cells	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
mutational	NULL
machinery	NULL
,	NULL
whereas	NULL
this	NULL
has	NULL
already	NULL
been	NULL
demonstrated	NULL
for	NULL
reactive	NULL
GC	NULL
B	NULL
cells	NULL
in	NULL
previous	NULL
investigations	NULL
.	NULL
``	NULL

The	NULL
finding	NULL
of	NULL
BCL-6	NULL
mutations	NULL
in	NULL
patients	NULL
with	NULL
B-cell-derived	NULL
HD	NULL
raises	NULL
the	NULL
question	NULL
of	NULL
the	NULL
role	NULL
these	NULL
alterations	NULL
play	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
HD	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
we	NULL
analyzed	NULL
the	NULL
position	NULL
of	NULL
the	NULL
BCL-6	NULL
mutations	NULL
and	NULL
compared	NULL
these	NULL
findings	NULL
with	NULL
previously	NULL
published	NULL
data	NULL
described	NULL
for	NULL
B-cell	NULL
NHLS	NULL
as	NULL
well	NULL
as	NULL
with	NULL
the	NULL
BCL-6	NULL
sequences	NULL
obtained	NULL
from	NULL
nonmalignant	NULL
cells	NULL
of	NULL
our	NULL
own	NULL
cHD	NULL
cases	NULL
.	NULL

In	NULL
3	NULL
of	NULL
4	NULL
B-cell-type	NULL
HD	NULL
cases	NULL
,	NULL
the	NULL
detected	NULL
BCL-6	NULL
mutations	NULL
represent	NULL
single	NULL
base	NULL
substitutions	NULL
not	NULL
previously	NULL
described	NULL
or	NULL
which	NULL
are	NULL
located	NULL
in	NULL
known	NULL
mutational	NULL
hotspots	NULL
(	NULL
RGWY	NULL
motif	NULL
)	NULL
.	NULL
``	NULL

These	NULL
alterations	NULL
can	NULL
be	NULL
considered	NULL
as	NULL
irrelevant	NULL
somatic	NULL
mutations	NULL
not	NULL
affecting	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
.	NULL

In	NULL
the	NULL
remaining	NULL
case	NULL
,	NULL
however	NULL
,	NULL
a	NULL
deletion	NULL
of	NULL
thymidine	NULL
(	NULL
T	NULL
)	NULL
at	NULL
position	NULL
520	NULL
(	NULL
520delT	NULL
)	NULL
,	NULL
which	NULL
is	NULL
described	NULL
as	NULL
the	NULL
most	NULL
common	NULL
recurrent	NULL
mutation	NULL
in	NULL
B-cell	NULL
NHL	NULL
,	NULL
was	NULL
found	NULL
.	NULL
``	NULL

This	NULL
deletion	NULL
might	NULL
cause	NULL
an	NULL
up-regulation	NULL
of	NULL
BCL-6	NULL
gene	NULL
expression	NULL
,	NULL
ie	NULL
,	NULL
by	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
new	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
(	NULL
eg	NULL
,	NULL
MZF1	NULL
)	NULL
.	NULL

This	NULL
assumption	NULL
is	NULL
in	NULL
harmony	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
protein	NULL
expression	NULL
analysis	NULL
in	NULL
this	NULL
case	NULL
because	NULL
a	NULL
strong	NULL
expression	NULL
of	NULL
BCL-6	NULL
was	NULL
found	NULL
in	NULL
virtually	NULL
all	NULL
tumor	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
all	NULL
other	NULL
B-cell-derived	NULL
cHD	NULL
cases	NULL
,	NULL
the	NULL
HRS	NULL
cells	NULL
were	NULL
negative	NULL
for	NULL
BCL-6	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
a	NULL
few	NULL
scattered	NULL
tumor	NULL
cells	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
relevant	NULL
BCL-6	NULL
mutations	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
absence	NULL
of	NULL
BCL-6	NULL
protein	NULL
expression	NULL
,	NULL
in	NULL
all	NULL
but	NULL
one	NULL
case	NULL
of	NULL
the	NULL
References	NULL
BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
Â«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
B-cell	NULL
genotype	NULL
challenge	NULL
the	NULL
role	NULL
of	NULL
BCL-6	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
cHD	NULL
.	NULL

Based	NULL
on	NULL
previous	NULL
data	NULL
it	NULL
can	NULL
be	NULL
assumed	NULL
that	NULL
HRS	NULL
cells	NULL
represent	NULL
late	NULL
GC	NULL
B	NULL
cells	NULL
that	NULL
were	NULL
not	NULL
selected	NULL
for	NULL
antigen	NULL
affinity	NULL
and	NULL
carry	NULL
nonfunctional	NULL
Ig	NULL
rearrangements	NULL
in	NULL
approximately	NULL
30	NULL
%	NULL
of	NULL
cases	NULL
.	NULL
``	NULL

''	NULL
Furthermore	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
Ig	NULL
expression	NULL
is	NULL
not	NULL
due	NULL
to	NULL
crippled	NULL
Ig	NULL
mutations	NULL
,	NULL
but	NULL
rather	NULL
to	NULL
a	NULL
defective	NULL
transcription	NULL
machinery	NULL
.	NULL
``	NULL

The	NULL
absence	NULL
of	NULL
BCL-6	NULL
expression	NULL
fits	NULL
well	NULL
in	NULL
this	NULL
scenario	NULL
because	NULL
late	NULL
GC	NULL
B	NULL
cells	NULL
and	NULL
post-GC	NULL
B	NULL
cells	NULL
are	NULL
largely	NULL
BCL-6-	NULL
.	NULL

!	NULL

Â°	NULL
Thus	NULL
,	NULL
the	NULL
missing	NULL
BCL-6	NULL
expression	NULL
in	NULL
most	NULL
HRS	NULL
cells	NULL
can	NULL
be	NULL
interpreted	NULL
as	NULL
reminiscence	NULL
of	NULL
the	NULL
differentiation	NULL
stage	NULL
of	NULL
the	NULL
tumor	NULL
precursor	NULL
cells	NULL
.	NULL

The	NULL
complete	NULL
absence	NULL
of	NULL
BCL-6	NULL
mutations	NULL
in	NULL
T-cell-derived	NULL
cHD	NULL
cases	NULL
clearly	NULL
indicates	NULL
that	NULL
alterations	NULL
in	NULL
this	NULL
gene	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
this	NULL
type	NULL
of	NULL
HD	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
one	NULL
of	NULL
the	NULL
2	NULL
T-cell-derived	NULL
HD	NULL
cases	NULL
showed	NULL
,	NULL
despite	NULL
the	NULL
absence	NULL
of	NULL
BCL-6	NULL
mutations	NULL
,	NULL
an	NULL
expression	NULL
of	NULL
BCL-6	NULL
could	NULL
reflect	NULL
a	NULL
derivation	NULL
from	NULL
BCL-6*	NULL
(	NULL
GC	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

Because	NULL
reactive	NULL
GC	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
carry	NULL
BCL-6	NULL
mutations	NULL
,	NULL
they	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
mutational	NULL
machinery	NULL
responsible	NULL
for	NULL
Ig	NULL
mutations	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
findings	NULL
in	NULL
cHD	NULL
of	NULL
B-cell	NULL
type	NULL
,	NULL
where	NULL
the	NULL
transforma-tional	NULL
event	NULL
seems	NULL
to	NULL
be	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
GC	NULL
mutator	NULL
.	NULL
``	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
findings	NULL
that	NULL
the	NULL
molecular	NULL
events	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
pathogenesis	NULL
of	NULL
B-cell-derived	NULL
cHD	NULL
are	NULL
different	NULL
from	NULL
those	NULL
giving	NULL
rise	NULL
to	NULL
T-cell-derived	NULL
cHD	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
B-cell-derived	NULL
cHD	NULL
cases	NULL
carry	NULL
somatic	NULL
mutations	NULL
in	NULL
the	NULL
5'-noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
,	NULL
whereas	NULL
T-cell-derived	NULL
cHD	NULL
cases	NULL
,	NULL
as	NULL
well	NULL
as	NULL
GC	NULL
T	NULL
cells	NULL
,	NULL
were	NULL
unmutated	NULL
.	NULL

This	NULL
supports	NULL
a	NULL
2-entity	NULL
concept	NULL
for	NULL
B-	NULL
and	NULL
T-cell-derived	NULL
cHD	NULL
.	NULL

Because	NULL
only	NULL
one	NULL
case	NULL
carried	NULL
a	NULL
lymphoma-specific	NULL
recurrent	NULL
mutation	NULL
and	NULL
BCL-6	NULL
was	NULL
absent	NULL
from	NULL
the	NULL
HRS	NULL
cells	NULL
in	NULL
most	NULL
cases	NULL
,	NULL
BCL-6	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
relevant	NULL
for	NULL
the	NULL
pathogenesis	NULL
of	NULL
both	NULL
B-cell-	NULL
and	NULL
T-cell-type	NULL
cHD	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
D.	NULL
Jahnke	NULL
,	NULL
H.	NULL
Lammert	NULL
,	NULL
and	NULL
H.	NULL
Protz	NULL
for	NULL
their	NULL
excellent	NULL
technical	NULL
assistance	NULL
and	NULL
L.	NULL
Udvarhelyi	NULL
for	NULL
his	NULL
editorial	NULL
help	NULL
.	NULL

1	NULL
.	NULL

Pasqualucei	NULL
L	NULL
,	NULL
Migliazza	NULL
A	NULL
,	NULL
Fracchiolla	NULL
N	NULL
,	NULL
et	NULL
al	NULL
.	NULL

BCL-6	NULL
mutations	NULL
in	NULL
normal	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
:	NULL
evidence	NULL
of	NULL
somatic	NULL
hypermutation	NULL
acting	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
diffuse	NULL
large	NULL
cell	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
.	NULL

Blood	NULL
.	NULL

1994	NULL
;	NULL
83:1757-1759.	NULL
as	NULL
a	NULL
T	NULL
cell	NULL
lymphoma	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

2000	NULL
;	NULL
191:387-394	NULL
.	NULL
'	NULL

``	NULL
.	NULL

7	NULL
.	NULL

Capello	NULL
D	NULL
,	NULL
Vitolo	NULL
U	NULL
,	NULL
Pasqualucei	NULL
L	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Distribu-	NULL
12	NULL
.	NULL

Seitz	NULL
V	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Marafioti	NULL
T	NULL
,	NULL
Anagnostopoulos	NULL
outside	NULL
Ig	NULL
loci	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1998	NULL
;	NULL
tion	NULL
and	NULL
pattern	NULL
of	NULL
BCL-6	NULL
mutations	NULL
throughout	NULL
1	NULL
,	NULL
Assaf	NULL
C	NULL
,	NULL
Stein	NULL
H.	NULL
Detection	NULL
of	NULL
clonal	NULL
T-cell	NULL
re-95:11816-11821.	NULL
the	NULL
spectrum	NULL
of	NULL
B-cell	NULL
neoplasia	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95	NULL
:	NULL
ceptor	NULL
gamma-chain	NULL
gene	NULL
rearrangements	NULL
in	NULL
2	NULL
.	NULL

Shen	NULL
HM	NULL
,	NULL
Peters	NULL
A	NULL
,	NULL
Baron	NULL
B	NULL
,	NULL
Zhu	NULL
X	NULL
,	NULL
Storb	NULL
U.	NULL
Mu-	NULL
651-659	NULL
.	NULL

Reed-Sternberg	NULL
cells	NULL
of	NULL
classic	NULL
Hodgkin	NULL
disease	NULL
.	NULL

tation	NULL
of	NULL
BCL-6	NULL
gene	NULL
in	NULL
normal	NULL
B	NULL
cells	NULL
by	NULL
the	NULL
pro-	NULL
8	NULL
.	NULL

-	NULL
Hummel	NULL
M	NULL
,	NULL
Ziemann	NULL
K	NULL
,	NULL
Lammert	NULL
H	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Sabat-	NULL
Blood	NULL
.	NULL

2000	NULL
;	NULL
95:3020-3024.	NULL
cess	NULL
of	NULL
somatic	NULL
hypermutation	NULL
of	NULL
Ig	NULL
genes	NULL
.	NULL

Sci-	NULL
tini	NULL
E	NULL
,	NULL
Stein	NULL
H.	NULL
Hodgkin	NULL
's	NULL
disease	NULL
with	NULL
monoclonal	NULL
13	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Expres-ence	NULL
.	NULL

1998	NULL
;	NULL
280:1750-1752.	NULL
and	NULL
polyclonal	NULL
populations	NULL
of	NULL
Reed-Stemberg	NULL
cells	NULL
sion	NULL
status	NULL
of	NULL
BCL-6	NULL
and	NULL
syndecan-1	NULL
identifies	NULL
3	NULL
.	NULL

Migliazza	NULL
A	NULL
,	NULL
Martinotti	NULL
S	NULL
,	NULL
Chen	NULL
W	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Frequent	NULL
[	NULL
see	NULL
comments	NULL
]	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
.	NULL

1995	NULL
;	NULL
333:901-906.	NULL
distinct	NULL
histogenetic	NULL
subtypes	NULL
of	NULL
Hodgkin	NULL
's	NULL
dis-somatic	NULL
hypermutation	NULL
of	NULL
the	NULL
5	NULL
'	NULL
noncoding	NULL
region	NULL
9	NULL
.	NULL

Kuppers	NULL
R	NULL
,	NULL
Rajewsky	NULL
K	NULL
,	NULL
Zhao	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Hodgkin	NULL
ease	NULL
.	NULL

Blood	NULL
.	NULL

1998	NULL
;	NULL
92:2220-2228.	NULL
of	NULL
the	NULL
BEN-	NULL
``	NULL
6	NULL
gene	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

disease	NULL
:	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
14	NULL
.	NULL

Cordell	NULL
JL	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Erber	NULL
WN	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Immuncen-Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1995	NULL
;	NULL
92:12520-12524.	NULL
picked	NULL
from	NULL
histological	NULL
sections	NULL
show	NULL
clonal	NULL
im-	NULL
zymatic	NULL
labeling	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
using	NULL
4	NULL
.	NULL

Szereday	NULL
Z	NULL
,	NULL
Csernus	NULL
B	NULL
,	NULL
Nagy	NULL
M	NULL
,	NULL
Laszlo	NULL
T	NULL
,	NULL
munoglobulin	NULL
gene	NULL
rearrangements	NULL
and	NULL
appear	NULL
immune	NULL
complexes	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
Warnke	NULL
RA	NULL
,	NULL
Matolcsy	NULL
A.	NULL
Somatic	NULL
mutation	NULL
of	NULL
the	NULL
to	NULL
be	NULL
derived	NULL
from	NULL
B	NULL
cells	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
monoclonal	NULL
anti-alkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
5	NULL
'	NULL
noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
is	NULL
associ-	NULL
development	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1994	NULL
;	NULL
91	NULL
:	NULL
complexes	NULL
)	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
.	NULL

1984	NULL
;	NULL
32	NULL
:	NULL
ated	NULL
with	NULL
intraclonal	NULL
diversity	NULL
and	NULL
clonal	NULL
selection	NULL
10962-10966	NULL
.	NULL

219-229.	NULL
in	NULL
histological	NULL
transformation	NULL
of	NULL
follicular	NULL
lym-	NULL
10	NULL
.	NULL

Kanzler	NULL
H	NULL
,	NULL
Hansmann	NULL
ML	NULL
,	NULL
Kapp	NULL
U	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Molecu-	NULL
15	NULL
.	NULL

Norton	NULL
AJ	NULL
,	NULL
Jordan	NULL
S	NULL
,	NULL
Yeomans	NULL
P.	NULL
Brief	NULL
,	NULL
high-phoma	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
.	NULL

2000	NULL
;	NULL
156:1017-1024.	NULL
lar	NULL
single	NULL
cell	NULL
analysis	NULL
demonstrates	NULL
the	NULL
deriva-	NULL
temperature	NULL
heat	NULL
denaturation	NULL
(	NULL
pressure	NULL
cook-5	NULL
.	NULL

Lossos	NULL
IS	NULL
,	NULL
Levy	NULL
R.	NULL
Mutation	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
'	NULL
tion	NULL
of	NULL
a	NULL
peripheral	NULL
blood-derived	NULL
cell	NULL
line	NULL
(	NULL
L1236	NULL
)	NULL
ing	NULL
)	NULL
:	NULL
a	NULL
simple	NULL
and	NULL
effective	NULL
method	NULL
of	NULL
antigen	NULL
noncoding	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
from	NULL
the	NULL
Hodgkin/Reed-Stemberg	NULL
cells	NULL
of	NULL
a	NULL
retrieval	NULL
for	NULL
routinely	NULL
processed	NULL
tissues	NULL
.	NULL

J	NULL
Pathol	NULL
.	NULL

non-Hodgkin	NULL
lymphoma	NULL
:	NULL
evidence	NULL
for	NULL
recurrent	NULL
Hodgkin	NULL
's	NULL
lymphoma	NULL
patient	NULL
.	NULL

Blood	NULL
.	NULL

1996	NULL
;	NULL
87	NULL
:	NULL
1994	NULL
;	NULL
173:371-379.	NULL
mutations	NULL
and	NULL
intraclonal	NULL
heterogeneity	NULL
.	NULL

Blood	NULL
.	NULL

3429-3436	NULL
.	NULL

16	NULL
.	NULL

Marafioti	NULL
T	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Anagnostopoulos	NULL
I	NULL
,	NULL
et	NULL
al	NULL
.	NULL

2000	NULL
;	NULL
95:1400-1405	NULL
.	NULL

11	NULL
.	NULL

Muschen	NULL
M	NULL
,	NULL
Rajewsky	NULL
K	NULL
,	NULL
Brauninger	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Origin	NULL
of	NULL
nodular	NULL
lymphocyte-predominant	NULL
6	NULL
.	NULL

Lo	NULL
CF	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Lista	NULL
F	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Rearrangements	NULL
of	NULL
Rare	NULL
occurrence	NULL
of	NULL
classical	NULL
Hodgkin	NULL
's	NULL
disease	NULL
Hodgkin	NULL
's	NULL
disease	NULL
from	NULL
a	NULL
clonal	NULL
expansion	NULL
of	NULL
BLOOD	NULL
,	NULL
15	NULL
APRIL	NULL
2001	NULL
Â«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
8	NULL
17	NULL
.	NULL

18	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

highly	NULL
mutated	NULL
germinal-center	NULL
B	NULL
cells	NULL
[	NULL
see	NULL
comments	NULL
]	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
.	NULL

1997	NULL
;	NULL
337:453-458	NULL
.	NULL

Marafioti	NULL
T	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Foss	NULL
HD	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
represent	NULL
an	NULL
expansion	NULL
of	NULL
a	NULL
single	NULL
clone	NULL
originating	NULL
from	NULL
a	NULL
germinal	NULL
center	NULL
B-cell	NULL
with	NULL
functional	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
but	NULL
defective	NULL
immunoglobulin	NULL
transcription	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:1443-1450	NULL
.	NULL

Kanzler	NULL
H	NULL
,	NULL
Kuppers	NULL
R	NULL
,	NULL
Hansmann	NULL
ML	NULL
,	NULL
Rajewsky	NULL
K.	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
represent	NULL
the	NULL
outgrowth	NULL
of	NULL
a	NULL
19	NULL
.	NULL

BCL-6	NULL
MUTATIONS	NULL
IN	NULL
eHD	NULL
OF	NULL
B-	NULL
AND	NULL
T-CELL	NULL
TYPE	NULL
dominant	NULL
tunor	NULL
clone	NULL
derived	NULL
from	NULL
(	NULL
crippled	NULL
)	NULL
germi-	NULL
21.	NULL
nal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1996	NULL
;	NULL
184:1495-1505	NULL
.	NULL

Falini	NULL
B	NULL
,	NULL
Bigerna	NULL
B	NULL
,	NULL
Pasqualucci	NULL
L	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Distinctive	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Blood	NULL
.	NULL

1996	NULL
;	NULL
87:465-471.	NULL
.	NULL

Marafioti	NULL
T	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Anagnostopoulos	NULL
I	NULL
,	NULL
Foss	NULL
22	NULL
.	NULL

HD	NULL
,	NULL
Huhn	NULL
D	NULL
,	NULL
Stein	NULL
H.	NULL
Classical	NULL
Hodgkin	NULL
disease	NULL
and	NULL
follicular	NULL
lymphoma	NULL
originating	NULL
from	NULL
the	NULL
same	NULL
germinal	NULL
center	NULL
B	NULL
cell	NULL
.	NULL

J	NULL
Clin	NULL
Oncol	NULL
.	NULL

1999	NULL
;	NULL
17:3804-3809	NULL
.	NULL

2405	NULL
Brauninger	NULL
A	NULL
,	NULL
Hansmann	NULL
ML	NULL
,	NULL
Strickler	NULL
JG	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Identification	NULL
of	NULL
common	NULL
germinal-center	NULL
B-cell	NULL
precursors	NULL
in	NULL
two	NULL
patients	NULL
with	NULL
both	NULL
Hodgkin	NULL
's	NULL
disease	NULL
and	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
[	NULL
see	NULL
comments	NULL
]	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
.	NULL

1999	NULL
;	NULL
340:1239-1247	NULL
.	NULL

Wolf	NULL
J	NULL
,	NULL
Kapp	NULL
U	NULL
,	NULL
Bohlen	NULL
H	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
advanced	NULL
Hodgkin	NULL
's	NULL
lymphoma	NULL
give	NULL
rise	NULL
to	NULL
permanently	NULL
growing	NULL
Hodgkin-Reed	NULL
Sternberg	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

1996	NULL
;	NULL
87:3418-3428	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Â®	NULL
2001	NULL
97	NULL
:	NULL
2401-2405	NULL
doi:10.1182/blood.V97.8.2401	NULL
Analysis	NULL
of	NULL
BCL-6	NULL
mutations	NULL
in	NULL
classic	NULL
Hodgkin	NULL
disease	NULL
of	NULL
the	NULL
B-	NULL
and	NULL
T-cell	NULL
type	NULL
Volkhard	NULL
Seitz	NULL
,	NULL
Michael	NULL
Hummel	NULL
,	NULL
Ioannis	NULL
Anagnostopoulos	NULL
and	NULL
Harald	NULL
Stein	NULL
4	NULL
,	NULL
8	NULL
5	NULL
p	NULL
'	NULL
ï¬	NULL
'	NULL
f	NULL
)	NULL
..	NULL
os	NULL
2101	NULL
%	NULL
N	NULL
@	NULL
0	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/97/8/2401	NULL
.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

